Adherence to anti-retroviral therapy (ART) regimen is essential for successful treatment and sustained viral control. Optimal adherence is the compliance to ART that achieves a sustained plasma drug concentration that suppresses viral replication. The objective of this study is to assess ART adherence and its determinants at Agaro Health Center ART Clinic, South Western Ethiopia. Facility-based cross sectional study was conducted from June 9-29, 2011. Patients were interviewed to collect adherence related information by using pretested semi-structured questionnaire. Subsequent charts of prescribed medications were reviewed using a pretested data collection format. A total of 209 respondents were included in the study, of which 127 (60.8%) were females and 82 (39.2%) were males. The average adherence rate was 98.1% among males and 99.5% among females. The overall average adherence rate among the respondents was 98.8%. One hundred sixty one (77.0%) respondents had a 100% adherence rate, 15 (7.2%) patients had a 93.3% adherence rate and the remaining 33 (15.8%) patients had adherence rate between 95 and 98% on average. The common reasons for missing of the prescribed doses were forgetting 27 (39.7%), being too busy 20 (29.4%), away from home 17 (25.0%) and being extremely ill 4 (5.9%). Of all the variables, sex, living alone, monthly income, use of stimulants and medications in addition to ART were significantly associated with non-adherence. The adherence rate among the study participants was found to be optimal, and near perfect adherence need to be maintained to obtain the optimum therapeutic outcome. Keywords: Adherence; antiretroviral therapy; Ethiopia; prevalence Özet Başarılı tedavi ve kalıcı viral kontrol için antiretroviral tedaviye (ART) uyum esastır. Viral repliksayonu baskılayan sürekli plazma ilaç konsantrasyonuna ulaşan ART uyunçu optimal uyumdur. Bu çalışmanın amacı, Güney Batı Etiyopya'da Agora Sağlık Merkezi ART Kliniği'nde ART'a uyma ve bunun belirleyicilerini saptamaktır. Olanak-tabanlı çapraz kesitli çalışma 9-29 Haziran 2011'de gerçekleştirildi. Ön testi yapılmış yarı-yapılandırılmış anket kullanarak uyuma ilişkin bilgileri toplamak için hastalarla görüşüldü. Reçetelenmiş ilaçların kayıtları ön testi yapılmış veri toplam formatı kullanılarak derlendi. Yüz yirmi yedisi (%60.8) bayan ve 82'si erkek (%39.2) olan toplam 209 cevap verenler bu çalışmaya alındı. Ortalama uyma oranı erkerlerde %98.1 ve bayanlarda %99.5 idi. Cevap verenlerin arasında ortalama uyma oranı %98.8 idi. Yüz altmış bir cevap verenin (%77.0) %100 uyma oranı vardı, 15 hastanın (%7.2) %93.3 uyma oranı ve kalan 33 hastanın (15.8%) uyma oranı ortalama %95-98 arasındaydı. Reçete edilen dozların alınmamasının genel nedenleri unutma 27 (%39.7), çok yoğun olma 20 (%29.4), evden uzakta olma 17 (%25.0) ve çok hasta olma 4 (5.9%) idi. Diğer bütün değişkenler, cinsiyet, tek başına yaşama, aylık gelir, ART'ye ilaveten stimulanların ve ilaçların kullanılması anlamlı olarak uymama ile ilişkiliydi. Çalışmaya katılanlar arasında uyma oranı optimal bulundu ve mükemmele yakın uyma optimum terapötik sonuç almak için sürdürülmesi gereklidir.
Introduction
HIV/AIDS is one of the most destructive epidemics the world has ever witnessed. In 2007 an estimated 33.2 million people were living with HIV (PLHIV) worldwide, while 2.5 million of these people were children under 15 years old (1) . The advent of potent antiretroviral therapy (ART) in1996 has changed the way people in the world view Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (HIV/AIDS). Though the treatment does not provide cure and free of side effects, it has dramatically improved rates of morbidity and mortality, improved quality of life, revitalized community and transformed perception of HIV/AIDS from a plague to a manageable chronic illness (2).
Adherence is described as engagement and accurate participation of informed patient in a treatment care plan. It includes entering into and continuing in a programmed treatment care plan such as meeting appointments and tests as scheduled. Adherence to treatment encompasses more than adherence to medications like ARV (2) . Adherence to Antiretroviral Therapy (ART) is measured by a variety of methods with the most commonly used methods being self-reporting by patients, pill counts, review of pharmacy records and Medication Event Monitoring System (MEMS) caps. All methods have their shortcomings. No gold standard has as yet been found for evaluating adherence to medication to date. Measuring medication adherence in clinical settings has not always been easy because common methods such as pill counts are not objective enough and the more accurate measures of adherence such as druglevel monitoring are expensive, can be inconvenient, difficult to implement in resource poor settings and not very relevant since it can only practically be done intermittently and appears to be only sensitive for identifying very low levels of adherence. However, patients' clinic attendance for medication refills can easily be monitored by the health staff even in resource-constrained settings (3).
Adherence to medication has become a major issue in the treatment of HIV-infected individuals and an important determinant of the outcome of highly active antiretroviral therapy (HAART). Adherence to antiretroviral medication is believed to be a crucial component in maintaining therapeutic drug levels, ensuring virologic suppression, and reducing the risk of drug resistance (4) . There is a significant correlation between adherence to medication and virologic suppression (5). Antiretroviral Therapy (ART) is a combination of three or more antiviral drugs with at least one protease inhibitor or non-nucleoside analogue reverse transcriptase inhibitor. Treatment is initiated with a combination of three drugs (triple therapy); two nucleoside reverse transcriptase inhibitors (NRTIs) form the back bone, a protease inhibitor (PI) or if this is not possible, a non-nucleoside reverse transcriptase inhibitor (6) .
Appropriate use of antiretroviral therapy (ART) has improved the health of many human immunodeficiency virus (HIV) positive individuals who otherwise may have died. Notably, the efficacy of any treatment depends on sustained high levels of adherence to ART. But ART regimens are often complicated and can include varying dosing schedules, dietary requirements, and adverse effects. Adherence is a major predictor of the survival of individuals living with Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (HIV/AIDS) and poor adherence to treatment remains a major obstacle in the fight against the virus (7). Antiretroviral Therapy for HIV is increasingly being provided in diverse areas of the world, yet Adherence is one of the major challenges in the treatment process. This issue is particularly important in the context of various cultural settings, particularly in developing countries (8) .
Adherence to ART is crucial to ensure viral suppression, decrease the risk of disease progression and drug resistance (9) . Low levels of adherence lead to ARVs not working effectively and are linked to increase in the viral load, decreased CD4 count and an increased risk of the progression to AIDS. Resistance to ARVs in people living with HIV/AIDS (PLWHA) makes adherence very important as developing resistance to an ARV treatment regimen limits future treatment options. Assessment of adherence behavior is necessary for effective changes in health outcomes and effective treatment planning and for ensuring that changes in health outcomes can be attributed to the recommended regimen (10) . Therefore, this study was intended to provide information about Antiretroviral Therapy (ART) adherence and its determinants among HIV/AIDS patients being attended at Agaro Health Center. The aim of this study was to assess Antiretroviral therapy adherence and its determinants at Agaro Health Center ART Clinic, South Western Ethiopia.
Participants and Methods

Study setting
Agaro is one of the towns found in Jimma zone, located 45 km away from Jimma town, southwest Ethiopia. It is the second largest town in the zone next to Jimma town. According to the 2007 population and housing census report of Ethiopia the town has a total population of 25,719 people (11).
Institution-based cross sectional study was conducted by using semi-structured pretested questionnaire and information sheet from refill data to assess ART adherence and its determinants among HIV/AIDS patients attending Agaro Health Center ART clinic. In the town, there are 8 Rural Drug Vendors, 6 Drug Stores, 6 Clinics and one Health Center. The source population was all HIV/AIDS patients who were receiving ART care service in Agaro health center ART clinic and all HIV/AIDS adult patients who came for refill of ART drugs during data collection time fulfilling the inclusion criteria of 18 years and above, patients on Antiretroviral therapy at least for 3 months and patients who were willing to participate in the study were considered as the study population. The sample size was determined be 461 using single population proportion method assuming that 50% proportion of population possessing the characteristics of interest with 20% non-response rate. Therefore, using correction formula the study was conducted on a total of 209 HIV/AIDS adult patients who came to the Health Center ART clinic for refill during the study period June 9-29, 2011.
Data collection
A semi-structured Questionnaire was designed to collect information. It included basic demographic details, types of ART regimen, other medications written in each order sheet, relevant medical history, co-morbidities and common opportunistic infections, educational status, pre-conception and current substance use status and other factors associated with Anti-retroviral adherence. A face-to-face interview was conducted along with simultaneous review of medical charts. All the information about antiretroviral therapy use was collected from patients via interview and additional information was extracted from their medical charts. The questionnaire was pre-tested to assess the clarity, sensitivity, reaction, interview time to the study instrument and logistic materials. The questionnaire was pre tested on 5% of the patients to see the soundness of the questionnaire and to make necessary corrections prior to starting the study. All patients included in the pre-test procedure were excluded from participating in the study to avoid information contamination.
Statistics
The collected data was clearly categorized, entered in to software, edited, cleaned, and analyzed using Statistical Package for Social Sciences (SPSS) for Windows version 16. Descriptive statistics was performed to obtain summary values of the study variables, Chi square test was performed to observe the association between each dependent and independent variables. 95% confidence level was estimated and variables with significance P value <0.05 were considered for the final model as an independent predictor.
Ethical considerations
Before data collection started, permission was obtained from Jimma University Research review board and Agaro health center. The participants were also consulted and gave their written consent. Participation was on voluntary basis. Confidentiality was maintained by concealing the names of individuals and other distinguishing information.
Results
A total of 209 patients were included in the study and all of them consented and completed the interview. Of the total patients who were involved in the study 127 (60.8%) were females and 82 (39.2%) were males. Majority 91 (43.5%) of the respondents were in the age group between 28-37 years old. Ninety two (44.0%) patients were Muslims and 126 (60.3%) were from rural areas. Majority 91 (43.5%) of the patients were married and 77 (36.8%) were divorced where only 8 (3.8%) were found to be single (Table  1) . (Table 2 ). Majority 111 (53.1%) of the respondents were on D4T/3TC/NVP followed by ZDV/3TC/NVP 27 (12.9%) and only 2 patients were on ZDV/3TC/EFV (Table 3) . Among the 209 adult HIV/AIDS patients, 68 (32.5%) were on ART for 1-2years followed by 67 (32.1%) patients for 2-3 years and 7 patients were on ART for 4-5 years ( Figure 1 ). Figure  3) . Among all the variables, sex (P<0.001), living alone (P<0.001), low monthly income (P=0.021), stimulants and drinks nonuse (P=0.001) and medications other than ARV nonuse (P=0.013) were significantly associated with non-adherence ( Table  4 ). 
Discussion
In the present study, a total of 209 adult HIV/AIDS patients were involved in the study, of which 127 (60.8%) were females and 82 (39.2%) were males. Similar to our finding, in the study conducted in Addis Ababa and Togo females were more than males (12, 13) . From total respondents, majority 126 (60.3%) were from the rural area. This is may be due to the fact that some urban patients discontinue refill from Agaro Health Center and instead may attend in the nearby ART sites, either Jimma or Limmu Hospitals due to fear of stigma and discrimination in their residence areas.
Antiretroviral therapy adherence rate in the present study was relatively higher (98.8%) compared to findings from a study done on HIV-patients in Kenya (74%), Togo (89.8%) and Addis Ababa (93.1%) (12) (13) (14) . The adherence rate (98.8%) in the present study was comparable with the finding of the study conducted in Jimma, which was greater than 95% (15) . The higher rate of adherence in the present study may be due to the services provided at the ART clinic such as counseling on ART adherence and other services like ART drug information from NonGovernmental Organizations.
The present study found that females (99.5%) were more adherent to ART than males (98.1%). This may be due to the fact that males used stimulants and other social drugs which will affect adherence negatively than females. In line with our finding, the study done in Kenya revealed that one of nonadherence factor was the use of stimulants and local alcoholic drinks (14) and out of non-adherence patients, most men missed doses. Thus, significant association between sex of respondents and adherence to ART was observed (p<0.05).
Our study found that majority 158 (75.6%) of the respondents had faced one drug side effect in the last month before this study and 51 (24.40%) respondents were with no drug side effects. Skin rash was the most 48 (30.40%) common side effect as reported by the respondents.
In the present study, majority 179 (85.6%) of the respondents were taking medications in addition to ART such as cotrimoxazole 145 (69.4%), antitubercular drugs 27 (12.9%) and Acyclovir 7 (3.3%). Out of the respondents who were taking additional medications, 131 (73.2%) patients were adhered 100% and adherence was found to be between 90-95% in 20 (11.2%) patients.
The present study found that the main reasons for missing the doses were forgetting 27 (39.7%), being too busy 20 (29.4%), being away from home 17 (25.0%) and being extremely ill 4 (5.9%). This finding is consistent with the study conducted in Addis Ababa which indicated being too busy or forgetting (33.9%) and being away from home (27.5%) were the commonest reasons for missing medications. Similarly, a study done in Southwest Ethiopia also revealed that being away from home (21.2%) and being busy (21.2%) and feeling ill (30.3%) were the common reasons for missing medications (14) (15) (16) . On the other hand, study done in Jimma showed that in more than 75% of the cases the most common reasons of missing the medications were running out of medications, simply forgetting, feeling ill and being busy (17) .
In the present study, the mean adherence rate in the previous 30 days was found to be 98.8% and majority 161 (77.0%) of the respondents had 100% adherence, 28 (13.4%) had 96-99% adherence, and only 20 (9.6%) were found to have between 90-95% adherence. Contrary to our finding, the study conducted in Southwest Ethiopia revealed 94.3% of self-reported dose adherence (17) . Similarly, a study done in South Africa revealed 93.5% of adherence among the study participants (18) . The adherence rate in the present study is higher than the study in Southwest Ethiopia and South Africa. This difference in findings may be attributed to the continued awareness creation and public education about the merits of ART adherence that is being conducted by health professionals and other stakeholders in the study area. Moreover, the variation in the study areas and methodology might also partly explain the disparity in the reported rates of adherence.
In the present study, the assessment done in determining the correlates of adherence revealed that sex (P), living alone (P), monthly income (P=0.02), medications in addition to ARV (P=0.01), use of stimulants and local drinks (P=0.01) were significantly associated with non-adherence. This finding different from the study conducts in Kenya (14) , which revealed that sex and monthly income were not significantly associated with adherence(p>0.05) but age and level of education significantly associated with adherence(p<0.05). The reason may be due to age restriction, since this study done on only adult people. Here again the variation in the study areas and methodology might also partly explain the disparity in the factors affecting adherence.
The major limitation of this research was lack of availability of more objective measures of adherence like Medication Event Monitoring System (MEMS) devices and other devices to follow more accurate method of measuring adherence, shortage of time and budget constraint. The other limitation is that respondents might respond ideally rather than what practically exercise. However, despite this limitations, it is an explanatory study in an area where scare information is existing, therefore it adds to facts already known on the topic by providing the magnitude of adherence and information on adherence level and factors significantly associated with non-adherence.
Adherence rate to ART of Adult HIV/AIDS patients was found to be high. The main reasons for missing of the doses were forgetting, being too busy, being away from home and being ill. Socio-demographic characteristics (sex, living alone, monthly income) were significantly associated with non-adherence. Since over 95% adherence to HAART is required for adequate virological, immunological response and optimum therapeutic outcome, long term adherence strategies should take these factors into consideration.
